JP Morgan Private Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.23M | Sell |
10,943
-569
| -5% | -$72.3K | ﹤0.01% | 906 |
|
|
2023
Q2 | $1.68M | Sell |
11,512
-6,900
| -37% | -$938K | 0.01% | 623 |
|
|
2023
Q1 | $2.38M | Buy |
18,412
+1,862
| +11% | +$234K | 0.01% | 817 |
|
|
2022
Q4 | $2.11M | Buy |
16,550
+1,615
| +11% | +$187K | ﹤0.01% | 823 |
|
|
2022
Q3 | $1.56M | Buy |
14,935
+158
| +1% | +$17.3K | ﹤0.01% | 934 |
|
|
2022
Q2 | $1.55M | Sell |
14,777
-1,789
| -11% | -$212K | ﹤0.01% | 933 |
|
|
2022
Q1 | $2.12M | Sell |
16,566
-2,612
| -14% | -$315K | ﹤0.01% | 882 |
|
|
2021
Q4 | $2.37M | Buy |
19,178
+1,155
| +6% | +$151K | 0.01% | 841 |
|
|
2021
Q3 | $2.56M | Sell |
18,023
-29
| -0.2% | -$4.27K | 0.01% | 799 |
|
|
2021
Q2 | $2.82M | Sell |
18,052
-264
| -1% | -$42.8K | 0.01% | 752 |
|
|
2021
Q1 | $2.85M | Sell |
18,316
-679
| -4% | -$105K | 0.01% | 651 |
|
|
2020
Q4 | $2.84M | Sell |
18,995
-958
| -5% | -$135K | 0.01% | 623 |
|
|
2020
Q3 | $2.64M | Buy |
19,953
+826
| +4% | +$108K | 0.01% | 576 |
|
|
2020
Q2 | $2.22M | Sell |
19,127
-2,563
| -12% | -$295K | 0.01% | 554 |
|
|
2020
Q1 | $2.13M | Buy |
21,690
+3,965
| +22% | +$520K | 0.01% | 524 |
|
|
2019
Q4 | $2.58M | Buy |
17,725
+398
| +2% | +$54.9K | 0.01% | 568 |
|
|
2019
Q3 | $2.31M | Buy |
17,327
+2,537
| +17% | +$328K | 0.01% | 559 |
|
|
2019
Q2 | $1.69M | Sell |
14,790
-963
| -6% | -$113K | 0.01% | 623 |
|
|
2019
Q1 | $1.95M | Sell |
15,753
-1,506
| -9% | -$171K | 0.01% | 619 |
|
|
2018
Q4 | $1.74M | Sell |
17,259
-636
| -4% | -$71.5K | 0.01% | 601 |
|
|
2018
Q3 | $2.29M | Sell |
17,895
-3,285
| -16% | -$391K | 0.01% | 595 |
|
|
2018
Q2 | $2.29M | Buy |
21,180
+648
| +3% | +$70.5K | 0.01% | 576 |
|
|
2018
Q1 | $2.17M | Sell |
20,532
-3,142
| -13% | -$365K | 0.01% | 469 |
|
|
2017
Q4 | $2.77M | Sell |
23,674
-2,812
| -11% | -$318K | 0.02% | 426 |
|
|
2017
Q3 | $3.01M | Buy |
26,486
+888
| +3% | +$103K | 0.02% | 394 |
|
|
2017
Q2 | $3.19M | Sell |
25,598
-10,051
| -28% | -$1.19M | 0.02% | 375 |
|
|
2017
Q1 | $4.23M | Buy |
35,649
+3,070
| +9% | +$348K | 0.03% | 330 |
|
|
2016
Q4 | $3.26M | Buy |
32,579
+2,204
| +7% | +$236K | 0.03% | 350 |
|
|
2016
Q3 | $3.83M | Sell |
30,375
-3,347
| -10% | -$414K | 0.04% | 309 |
|
|
2016
Q2 | $3.94M | Buy |
33,722
+690
| +2% | +$78.1K | 0.04% | 307 |
|
|
2016
Q1 | $3.42M | Buy |
33,032
+395
| +1% | +$38.2K | 0.03% | 304 |
|
|
2015
Q4 | $3.25M | Buy |
32,637
+3,867
| +13% | +$378K | 0.03% | 282 |
|
|
2015
Q3 | $2.62M | Sell |
28,770
-5,675
| -16% | -$569K | 0.03% | 296 |
|
|
2015
Q2 | $3.65M | Buy |
34,445
+6,625
| +24% | +$733K | 0.04% | 284 |
|
|
2015
Q1 | $3.17M | Sell |
27,820
-210
| -0.7% | -$24K | 0.04% | 303 |
|
|
2014
Q4 | $3.09M | Buy |
28,030
+1,738
| +7% | +$183K | 0.04% | 309 |
|
|
2014
Q3 | $2.57M | Buy |
26,292
+127
| +0.5% | +$12.5K | 0.03% | 332 |
|
|
2014
Q2 | $2.64M | Buy |
26,165
+1,926
| +8% | +$188K | 0.04% | 259 |
|
|
2014
Q1 | $2.23M | Buy |
24,239
+7,889
| +48% | +$727K | 0.04% | 270 |
|
|
2013
Q4 | $1.48M | Buy |
16,350
+1,950
| +14% | +$169K | 0.03% | 293 |
|
|
2013
Q3 | $1.15M | Buy |
14,400
+1,045
| +8% | +$82.3K | 0.03% | 313 |
|
|
2013
Q2 | $972K | Buy |
+13,355
| New | +$999K | 0.02% | 324 |
|
Other funds holding ZBH
JP Morgan Private Wealth Advisors's ZBH Position: Q3 2023 in Review
JP Morgan Private Wealth Advisors reduced its Zimmer Biomet (ZBH) stake by 4.9% in Q3 2023, selling an estimated $72.3K and leaving 10,943 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #906.
JP Morgan Private Wealth Advisors first reported a position in ZBH in Q2 2013 and has held it in 42 quarters since. The position peaked at $4.23M in Q1 2017. 1,017 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.
- JP Morgan Private Wealth Advisors held 10,943 shares of Zimmer Biomet worth $1.23M as of Q3 2023.
- JP Morgan Private Wealth Advisors sold 569 Zimmer Biomet shares in Q3 2023, an estimated $72.3K.
- Zimmer Biomet made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #906 holding.
- JP Morgan Private Wealth Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 42 quarters since.
- JP Morgan Private Wealth Advisors's Zimmer Biomet position peaked at $4.23M in Q1 2017.
- 1,017 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.